RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
  Bladder
  Blood
  Bone Cancer
  Brain
  Breast Cancer
  Carcinogens
  Cervical Cancer
  Colon
  Endometrial
  Esophageal
  Gastric Cancer
  Liver Cancer
  Lung
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Skin
  Testicular Cancer
  Therapy
  Thyroid
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Breast Cancer Channel

subscribe to Breast Cancer newsletter
Latest Research : Cancer : Breast Cancer

   EMAIL   |   PRINT
Boost radiotherapy effective for ductal carcinoma in situ

Jul 10, 2006 - 7:08:00 PM , Reviewed by: Priya Saxena
Boost radiotherapy, in which a "boost" of 10–16 Gy of radiotherapy is given in addition to the normal radiotherapy treatment after surgery, is already known to work in invasive breast cancer, and especially so in younger women.

 
[RxPG] Radiotherapy of the whole breast followed by a boost could stop the very early stages of breast cancer from returning claim researchers from the international Rare Cancer Network in paper published online today by The Lancet Oncology. This strategy should therefore be considered in addition to surgery for patients with the breast-cancer precursor called ductal carcinoma in situ, or DCIS.

We had two main findings notes Guenther Gruber (Kantonsspital, Aarau, Switzerland), lead author of the study: "First, not using radiotherapy in young patients with DCIS resulted in an unacceptable number of women having their cancer return; and second, these patients benefit from an additional boost dose".

Boost radiotherapy, in which a "boost" of 10–16 Gy of radiotherapy is given in addition to the normal radiotherapy treatment after surgery, is already known to work in invasive breast cancer, and especially so in younger women. The researchers therefore decided to try out this technique in younger women, but with DCIS, an earlier stage of breast cancer.

Dr Gruber and colleagues analysed the records of 373 women aged 45 years or younger from 18 institutions throughout the world who had DCIS and had received breast-conserving surgery. About a sixth of the patients were not given any radiotherapy after surgery; almost half received radiotherapy without a boost; and the remaining two-fifths received radiotherapy with an extra boost. The researchers found that the risk of the cancer returning decreased progressively for each of these techniques – the most effective was radiotherapy with a boost.

So far, no randomised trials, the gold standard of assessment, have been done to assess the effects of boost radiotherapy in young women with DCIS. Dr Gruber therefore suggests that their results might mean that this technique will now be considered as a part of the armamentarium of breast conserving treatment, until randomised studies are done. "Of course", he adds, "radiotherapy has to be applied carefully, especially in regard to heart, lungs and the other breast".



Publication: The Lancet Oncology
On the web: www.thelancet.com 

Advertise in this space for $10 per month. Contact us today.


Related Breast Cancer News
Blood test predicts breast cancer recurrence
Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is a new therapeutic target for breast cancer
Smoking may have an association with breast cancer in women
Vitamins and calcium supplements appear to reduce the risk of breast cancer
Acupuncture has added benefits in breast cancer patients
Study finds higher risk of cancer recurrence in women with dense breasts
Physical activity after menopause reduces breast cancer
Genes responsible for susceptibility to breast cancer metastasis can be inherited
Oestrogen therapy of benefit in some women with metastatic cancer
Awry protein linked to breast cancer

Subscribe to Breast Cancer Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)